Anti-ADAM-30 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody targeting ADAM-30 (Q9UKF2), validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Pan
UniProt
Q9UKF2
Size
100ug
Cat. #
RP3ADAM30

In stock

SKU
RP-ADAM30

Options

As low as: $130.00

Target Overview

Disintegrin and metalloproteinase domain-containing protein 30 (ADAM-30, EC 3.4.24.-, UniProt Q9UKF2) is a 790-amino acid member of the ADAM metalloprotease family localized to late endosome membranes. ADAM-30 plays a documented role in lysosomal amyloid precursor protein (APP) processing by cleaving and activating cathepsin D (CTSD), which subsequently promotes APP degradation. This positions ADAM-30 within the endolysosomal proteolytic network relevant to neurodegenerative disease models. The ADAM family comprises transmembrane and secreted proteases with structural modules including metalloprotease, disintegrin, cysteine-rich, and cytoplasmic domains. While many ADAMs function as sheddases for cell-surface substrates, ADAM-30's endosomal localization and CTSD-activation function distinguish it from classical ectodomain-shedding family members. Researchers studying APP metabolism, endosomal proteolysis, and lysosomal enzyme activation pathways utilize ADAM-30 antibodies to probe its expression, subcellular distribution, and functional regulation in primary cells and tissue sections.

Background

ADAM-30 belongs to the ADAM (a disintegrin and metalloproteinase) family, a group of zinc-dependent metalloproteases involved in ectodomain shedding, cell adhesion, and intracellular signaling. Unlike many surface-active ADAMs, ADAM-30 localizes to late endosome membranes where it regulates proteolytic cascades within the endolysosomal system. The best-characterized function of ADAM-30 is its activation of procathepsin D (CTSD), a lysosomal aspartyl protease. Once cleaved by ADAM-30, mature CTSD degrades amyloid precursor protein (APP), linking ADAM-30 to pathways investigated in Alzheimer's disease and related neurodegenerative contexts. This APP-processing role was demonstrated in cell-based models showing that ADAM-30 depletion reduces CTSD maturation and alters APP turnover kinetics. Broader functional roles of the ADAM family in the nervous system have been reviewed, highlighting their contributions to synaptic remodeling, axon guidance, and neuroinflammation. Hsia et al. (2019) surveyed ADAM functions across mammalian neural development and homeostasis, underscoring the family's involvement in Notch and Eph receptor signaling, myelin maintenance, and injury responses. While ADAM-30 itself was not the primary focus, the review contextualizes how individual ADAM members occupy distinct niches within overlapping regulatory networks. Given ADAM-30's endosomal niche and cathepsin activation function, researchers employ validated antibodies to map its tissue expression, confirm subcellular localization by immunofluorescence, and assess its abundance in disease-relevant samples by Western blot and immunohistochemistry. Recent genomic studies have flagged ADAM30 loci in disease association scans, though functional follow-up remains limited. Wilhelm et al. (2025) identified ADAM30 among genes associated with type 2 diabetes mellitus risk in large biobank cohorts, suggesting potential metabolic or inflammatory roles beyond the nervous system. Such findings underscore the need for robust reagents to validate protein-level expression and localization across diverse tissue contexts.

References

  1. Wilhelm K et al (2025) Meta-evolutionary exome analysis identifies novel type 2 diabetes mellitus genes in the UK Biobank and all of us. PLoS Genet. PubMed · 10.1371/journal.pgen.1011889
  2. Hsia HE et al (2019) Functions of 'A disintegrin and metalloproteases (ADAMs)' in the mammalian nervous system. Cell Mol Life Sci. PubMed · 10.1007/s00018-019-03173-7

Additional Specifications

Gene Symbol ADAM30
UniProt ID Q9UKF2
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Pan
Pack Size 100ug
Immunogen (Cytoplasmic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 709-790.
Immunogen (Propeptide domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 28-198.
Immunogen (Propeptide domain)Synthetic peptide corresponding to the Propeptide domain of human ADAM-30 (UniProt Q9UKF2).
Alternate Names ADAM30, ADAM 30, Disintegrin and metalloproteinase domain-containing protein 30, EC 3.4.24.-

Frequently Asked Questions

What molecular weight band should I expect for ADAM-30 on Western blot?

ADAM-30 has a predicted molecular weight of approximately 87 kDa based on the 790-amino acid sequence. However, ADAM family proteins often migrate at apparent masses that differ from predicted values due to glycosylation and proteolytic processing. You may observe bands between 80-100 kDa depending on post-translational modifications. Because ADAM-30 localizes to late endosomes and may undergo maturation cleavage, lysates from different tissue sources or cell lines could yield additional lower-mass bands representing processed forms. Include a positive control lysate from cells known to express ADAM-30, and consider treating samples with deglycosylases if band interpretation is ambiguous.

What dilution should I start with for ADAM-30 Western blot?

We recommend starting at 1:1000 dilution for Western blot applications with this rabbit polyclonal antibody. This concentration has been validated in our hands and provides a good balance between signal and background for most mammalian cell lysates. If your ADAM-30 expression level is low or you are working with tissue lysates rather than overexpression models, you may need to titre up to 1:500. Conversely, if you encounter high background, dilute to 1:2000. Because ADAM-30 is an endosomal protein, enriching for membrane fractions rather than using whole-cell lysates may improve signal-to-noise ratio.

Will this ADAM-30 antibody cross-react with mouse or rat samples?

This antibody has been validated against human ADAM-30. Cross-reactivity with mouse and rat is predicted based on sequence homology in the immunogen region, but has not been experimentally validated by Triple Point Biologics. Human and mouse ADAM-30 share approximately 75-80 percent sequence identity, suggesting potential cross-reactivity. However, if you are working with rodent samples, we recommend treating the first experiment as a validation run. Include a human-derived positive control in parallel, and verify that the observed band corresponds to the expected molecular weight for rodent ADAM-30, which may differ slightly from the human ortholog.

Does ADAM-30 have multiple isoforms I need to account for?

ADAM-30 is primarily represented by a single full-length isoform in UniProt (Q9UKF2), spanning 790 amino acids. However, like other ADAM family members, ADAM-30 undergoes proteolytic maturation that removes the prodomain, generating a catalytically active form. Depending on your cell type and lysis conditions, you may detect both the zymogen and mature protease on Western blot. Additionally, because ADAM-30 functions in the endolysosomal compartment where proteolysis is active, you may observe degradation products or C-terminal fragments. If studying ADAM-30 processing is central to your work, consider using protease inhibitor cocktails during lysis and comparing reducing versus non-reducing conditions.

Can I use this antibody for immunofluorescence to visualize ADAM-30 in endosomes?

Triple Point Biologics antibodies are routinely validated for immunofluorescence applications, and this polyclonal format is generally compatible with IF protocols. Because ADAM-30 localizes to late endosomes, you should see punctate perinuclear staining in cells expressing the protein. Use methanol or paraformaldehyde fixation followed by permeabilization with 0.1-0.2 percent Triton X-100. Start with a 1:100 to 1:200 dilution and co-stain with late endosome markers such as Rab7 or LAMP1 to confirm colocalization. Keep in mind that ADAM-30 expression is often low in non-neuronal cells, so select a cell model with documented ADAM-30 expression or consider transient overexpression for method development.

What positive control should I use to validate ADAM-30 detection?

ADAM-30 expression is relatively restricted compared to ubiquitous ADAMs like ADAM10 or ADAM17. Brain tissue lysates, particularly from cortex or hippocampus, are reasonable positive controls given ADAM-30's role in amyloid precursor protein processing and relevance to neurodegenerative pathways. Alternatively, HEK293 or SH-SY5Y neuroblastoma cells express detectable endogenous ADAM-30. If endogenous levels are too low for reliable detection in your hands, transiently transfect cells with an ADAM-30 expression construct as a positive control. A lysate from non-transfected cells or ADAM-30 knockdown cells serves as a useful negative control to assess antibody specificity.

How should I prepare lysates to preserve ADAM-30 for Western blot?

ADAM-30 is a membrane-associated metalloprotease localized to endosomes, so lysis buffer composition matters. Use RIPA or a similar detergent-based buffer containing 1 percent NP-40 or Triton X-100 to solubilize membrane proteins effectively. Include a broad-spectrum protease inhibitor cocktail, and consider adding a metalloprotease inhibitor such as 10 mM EDTA or 1 mM 1,10-phenanthroline to prevent autocatalytic degradation or cleavage by other metalloproteases. Because ADAM-30 functions within the acidic endolysosomal compartment, avoid freeze-thaw cycles that may compromise membrane integrity. Prepare fresh lysates when possible, or snap-freeze aliquots in liquid nitrogen and store at -80°C for long-term use.

How should I store this ADAM-30 antibody and how long is it stable?

Store the antibody at -20°C upon arrival. Rabbit polyclonal antibodies in standard formulation with carrier protein and preservative are stable for at least 12 months under these conditions. Avoid repeated freeze-thaw cycles, which can reduce titre and increase aggregation. For routine use, aliquot the stock into single-use volumes and keep a working aliquot at 4°C for up to one month. Do not store diluted antibody; prepare fresh working dilutions in blocking buffer for each experiment. If you observe decreased signal or increased background over time, this typically indicates antibody degradation, and a fresh aliquot should be thawed.

Western blot validation for RP-ADAM30 — 1 panel across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

ADAM-30: Cytoplasmic domain — WB validation
WB · Panel 1 ADAM-30: Cytoplasmic domain

Custom validation studies available on request — contact us.

Also known as:

  • ADAM30
  • ADAM 30
  • Disintegrin and metalloproteinase domain-containing protein 30
  • EC 3.4.24.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →